CDMO Samsung Biologics
Business
CDMO Samsung Biologics Invests $347 Million to Acquire Land in the Incheon Free Economic Zone for Bio Campus II
Samsung Biologics, a leading contract development and manufacturing organization (CDMO), continues to grow. Already a world leader in capacity, operating three plants at its headquarters in Songdo, South Korea, the CDMO recently announced that its fourth plant will be...
- Advertisement -![spot_img]()
Latest News
How to motivate your employees
Are you seeking smart ways to keep your employees motivated and productive? A motivated workforce can be a significant...
- Advertisement -![spot_img]()